Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peng Yeh

Showing results (111-120 of 149) with videos related to

Pageof 15
Sort By:
Journal of the Formosan Medical Association = Taiwan Yi Zhi|December 26, 2016
A noninterventional observational registry of patients with multiple myeloma treated with lenalidomide in TaiwanShang-Yi Huang, Yuan-Bin Yu, Su-Peng Yeh, et al.
Anticancer Research|December 16, 2014
Safety and efficacy of pegylated liposomal doxorubicin-based adjuvant chemotherapy in patients with stage I-III triple-negative breast cancerMing-Yu Lien, Liang-Chih Liu, Hwei-Chung Wang, et al.
Hearing Research|October 22, 2024
Critical role of hepsin/TMPRSS1 in hearing and tectorial membrane morphogenesis: Insights from transgenic mouse modelsTing-Hua Yang, Yu-Chen Hsu, Peng Yeh, et al.
Leukemia Research|November 2, 2024
Safety and effectiveness of ruxolitinib in real-world patients with myelofibrosis: A 2-year observational study from TaiwanMing-Chung Kuo, Chien-Chin Lin, Hsuan-Yu Lin, et al.
Leukemia Research|January 2, 2013
Prognostic impact of allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia patients with internal tandem duplication of FLT3Po-Han Lin, Ching-Chan Lin, Hwai-I Yang, et al.
EMBO Molecular Medicine|March 26, 2013
Smurf2-mediated degradation of EZH2 enhances neuron differentiation and improves functional recovery after ischaemic strokeYung-Luen Yu, Ruey-Hwang Chou, Woei-Cherng Shyu, et al.
Blood Advances|July 24, 2025
Long-term results from the AGILE study of azacitidine plus ivosidenib vs placebo in newly diagnosed IDH1-mutated AMLPau Montesinos, Dylan M Marchione, Christian Récher, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 31, 2022
Isatuximab-Pomalidomide-Dexamethasone Versus Pomalidomide-Dexamethasone in East Asian Patients With Relapsed/Refractory Multiple Myeloma: ICARIA-MM Subgroup AnalysisKazutaka Sunami, Takashi Ikeda, Shang-Yi Huang, et al.
Scientific Reports|September 14, 2017
A Phase II Study of Arginine Deiminase (ADI-PEG20) in Relapsed/Refractory or Poor-Risk Acute Myeloid Leukemia PatientsHui-Jen Tsai, Shih Sheng Jiang, Wen-Chun Hung, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|October 29, 2025
Consensus of the Hematology Society of Taiwan on the management of paroxysmal nocturnal hemoglobinuria (PNH)Wei-Han Huang, Hsin-An Hou, Wen-Chien Chou, et al.
Pageof 15

Showing results (111-120 of 149) with videos related to

Sort By:
Pageof 15
Journal of the Formosan Medical Association = Taiwan Yi Zhi|December 26, 2016
A noninterventional observational registry of patients with multiple myeloma treated with lenalidomide in TaiwanShang-Yi Huang, Yuan-Bin Yu, Su-Peng Yeh, et al.
Anticancer Research|December 16, 2014
Safety and efficacy of pegylated liposomal doxorubicin-based adjuvant chemotherapy in patients with stage I-III triple-negative breast cancerMing-Yu Lien, Liang-Chih Liu, Hwei-Chung Wang, et al.
Hearing Research|October 22, 2024
Critical role of hepsin/TMPRSS1 in hearing and tectorial membrane morphogenesis: Insights from transgenic mouse modelsTing-Hua Yang, Yu-Chen Hsu, Peng Yeh, et al.
Leukemia Research|November 2, 2024
Safety and effectiveness of ruxolitinib in real-world patients with myelofibrosis: A 2-year observational study from TaiwanMing-Chung Kuo, Chien-Chin Lin, Hsuan-Yu Lin, et al.
Leukemia Research|January 2, 2013
Prognostic impact of allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia patients with internal tandem duplication of FLT3Po-Han Lin, Ching-Chan Lin, Hwai-I Yang, et al.
EMBO Molecular Medicine|March 26, 2013
Smurf2-mediated degradation of EZH2 enhances neuron differentiation and improves functional recovery after ischaemic strokeYung-Luen Yu, Ruey-Hwang Chou, Woei-Cherng Shyu, et al.
Blood Advances|July 24, 2025
Long-term results from the AGILE study of azacitidine plus ivosidenib vs placebo in newly diagnosed IDH1-mutated AMLPau Montesinos, Dylan M Marchione, Christian Récher, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 31, 2022
Isatuximab-Pomalidomide-Dexamethasone Versus Pomalidomide-Dexamethasone in East Asian Patients With Relapsed/Refractory Multiple Myeloma: ICARIA-MM Subgroup AnalysisKazutaka Sunami, Takashi Ikeda, Shang-Yi Huang, et al.
Scientific Reports|September 14, 2017
A Phase II Study of Arginine Deiminase (ADI-PEG20) in Relapsed/Refractory or Poor-Risk Acute Myeloid Leukemia PatientsHui-Jen Tsai, Shih Sheng Jiang, Wen-Chun Hung, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|October 29, 2025
Consensus of the Hematology Society of Taiwan on the management of paroxysmal nocturnal hemoglobinuria (PNH)Wei-Han Huang, Hsin-An Hou, Wen-Chien Chou, et al.
Pageof 15